Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F14%3A%230004027" target="_blank" >RIV/00023728:_____/14:#0004027 - isvavai.cz</a>

Výsledek na webu

<a href="http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=R1YSBTEQp1pzDbZIep4&page=1&doc=1" target="_blank" >http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=R1YSBTEQp1pzDbZIep4&page=1&doc=1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.bone.2013.11.011" target="_blank" >10.1016/j.bone.2013.11.011</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment

Popis výsledku v původním jazyce

Teriparatide treatment resulted in significant increases of MAR in the endocortical, and MS/BS% in the periosteal compartment in the ALN-pretreated group. Most indices of bone formation remained lower in the ALN-pretreated group compared with the TN group at study end. Cortical porosity and cortical thickness were significantly increased in the ALN-pretreated group after teriparatide treatment. Our results suggest that 24 months of teriparatide treatment increases cortical bone formation and cortical turnover in patients who were either TN or had previous ALN therapy

Název v anglickém jazyce

Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment

Popis výsledku anglicky

Teriparatide treatment resulted in significant increases of MAR in the endocortical, and MS/BS% in the periosteal compartment in the ALN-pretreated group. Most indices of bone formation remained lower in the ALN-pretreated group compared with the TN group at study end. Cortical porosity and cortical thickness were significantly increased in the ALN-pretreated group after teriparatide treatment. Our results suggest that 24 months of teriparatide treatment increases cortical bone formation and cortical turnover in patients who were either TN or had previous ALN therapy

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Bone

ISSN

1873-2763

e-ISSN

—

Svazek periodika

59

Číslo periodika v rámci svazku

Februar

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

139-147

Kód UT WoS článku

000329558600018

EID výsledku v databázi Scopus

—